About NexMR
NexMR is a Healthcare company based in Switzerland founded in 2021, and was acquired by Magritek in July 2026. Software solutions for NMR-drug discovery pipelines are provided. NexMR offers products and services including Light-sources for high-field NMR, Ultrafast NMR Fragment library, Ultrafast NMR reagents kit, Automated screening analysis, and Automated affinity determination analysis. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
NexMR was founded in 2021 in Switzerland as a provider of software solutions tailored to NMR-based drug discovery pipelines. Operations center on developing tools that support pharmaceutical research and development processes. Services include software for analyzing nuclear magnetic resonance data to streamline drug candidate identification and validation. The company maintains its headquarters in Switzerland, serving the biotech sector through its online platform at nexmr.com.
Products & Services of NexMR
NexMR offers a comprehensive portfolio of products and services, including Light-sources for high-field NMR, Ultrafast NMR Fragment library, Ultrafast NMR reagents kit, Automated screening analysis, and Automated affinity determination analysis.
Enables 100-fold faster NMR measurements for drug discovery
Reduces sample preparation time for NMR experiments
Optimizes performance and reduces sample concentration
Provides ultrafast data analysis for screening applications
Facilitates automated determination of molecular affinities
Funding Insights of NexMR
- Total Rounds 2
- Last Round Grant — $161,820
- First Round $10,717
(Mar 2022)
- Investors Count 1
All 2 funding rounds of NexMR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $161,820 | Grant | – | – | |
| Mar 2022 | $10,717 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in NexMR
NexMR has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Magritek and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland | ||
Provider of NMR and MRI solutions for industries and research laboratories | 2004 | magritek.com | Wellington, New Zealand |
Investor details for NexMR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NexMR
4 dated milestones of NexMR across 5 years, from founding to its latest funding, stage changes and deals.
- Founded NexMR is founded.
- Funding First funding round of $11K.
- Funding Latest funding round, Grant, of $162K.
- Exit Acquired by Magritek.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nexmr
Complete news archive for NexMR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NexMR
NexMR was founded in 2021 and raised its 1st funding round 1 year after it was founded.
NexMR is headquartered in Switzerland.
NexMR was founded in 2021 in Switzerland as a provider of software solutions tailored to NMR-based drug discovery pipelines. Operations center on developing tools that support pharmaceutical research and development processes. Services include software for analyzing nuclear magnetic resonance data to streamline drug candidate identification and validation. The company maintains its headquarters in Switzerland, serving the biotech sector through its online platform at nexmr.com.
NexMR offers Light-sources for high-field NMR, Ultrafast NMR Fragment library, Ultrafast NMR reagents kit, Automated screening analysis, and Automated affinity determination analysis.
NexMR has 2 investors. Key investors include Magritek, and Venture Kick.
Yes. NexMR was acquired by Magritek in July 2026.